Actualités Circio Holding Asa - 0RIS | Actions London Stock Exchange

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Targovax ASA strengthens management with Lubor Gaal as Chief Financial Officer

Targovax ASA strengthens management with Lubor Gaal as Chief Financial Officer PR Newswire OSLO, Norway, Feb. 28, 2022 OSLO, Norway, Feb. 28...

Targovax ASA strengthens management with Lubor Gaal as Chief Financial Officer

Targovax ASA strengthens management with Lubor Gaal as Chief Financial Officer PR Newswire OSLO, Norway, Feb. 28, 2022 OSLO, Norway, Feb. 28...

Targovax ASA: Targovax awarded NOK 8.2m grant by Innovation Norway

Targovax ASA: Targovax awarded NOK 8.2m grant by Innovation Norway PR Newswire OSLO, Norway, Jan. 12, 2022 OSLO, Norway, Jan. 12, 2022...

Targovax ASA: Targovax awarded NOK 8.2m grant by Innovation Norway

Targovax ASA: Targovax awarded NOK 8.2m grant by Innovation Norway PR Newswire OSLO, Norway, Jan. 12, 2022 OSLO, Norway, Jan. 12, 2022...

Targovax ASA: ONCOS-102 achieves 25.0 months median overall survival in first line mesothelioma

Targovax ASA: ONCOS-102 achieves 25.0 months median overall survival in first line mesothelioma PR Newswire OSLO, Norway, Dec. 20, 2021 The...

Targovax ASA: ONCOS-102 achieves 25.0 months median overall survival in first line mesothelioma

Targovax ASA: ONCOS-102 achieves 25.0 months median overall survival in first line mesothelioma The median overall survival (mOS) was 25.0 months...

Targovax ASA: Third quarter 2021 results

Targovax ASA: Third quarter 2021 results PR Newswire OSLO, Norway, Nov. 4, 2021 OSLO, Norway, Nov. 4, 2021 /PRNewswire/ -- Targovax ASA (OSE:...

Targovax ASA: Third quarter 2021 results

Targovax ASA: Third quarter 2021 results PR Newswire OSLO, Norway, Nov. 4, 2021 OSLO, Norway, Nov. 4, 2021 /PRNewswire/ -- Targovax ASA (OSE:...

Targovax: Presentation material for today's webcast

Targovax: Presentation material for today's webcast PR Newswire OSLO, Norway, Oct. 25, 2021 OSLO, Norway, Oct. 25, 2021 /PRNewswire/ -- Targovax...

Targovax: Presentation material for today's webcast

Targovax: Presentation material for today's webcast PR Newswire OSLO, Norway, Oct. 25, 2021 OSLO, Norway, Oct. 25, 2021 /PRNewswire/ -- Targovax...

Targovax ASA appoints Dr. Erik Digman Wiklund as new CEO

Targovax ASA appoints Dr. Erik Digman Wiklund as new CEO PR Newswire OSLO, Norway, Oct. 20, 2021 OSLO, Norway, Oct. 20, 2021 /PRNewswire/...

Targovax ASA appoints Dr. Erik Digman Wiklund as new CEO

Targovax ASA appoints Dr. Erik Digman Wiklund as new CEO PR Newswire OSLO, Norway, Oct. 20, 2021 OSLO, Norway, Oct. 20, 2021 /PRNewswire/...

Targovax to present at upcoming conferences

Targovax to present at upcoming conferences PR Newswire OSLO, Norway, Oct. 19, 2021 OSLO, Norway, Oct. 19, 2021 /PRNewswire/ -- Targovax...

Targovax to present at upcoming conferences

Targovax to present at upcoming conferences PR Newswire OSLO, Norway, Oct. 19, 2021 OSLO, Norway, Oct. 19, 2021 /PRNewswire/ -- Targovax...

Targovax ASA: Two abstracts accepted at the SITC Congress

Targovax ASA: Two abstracts accepted at the SITC Congress PR Newswire OSLO, Norway, Oct. 6, 2021 OSLO, Norway, Oct. 6, 2021 /PRNewswire/...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Circio Holding Asa (0RIS)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

0RIS Actualités

Targovax ASA strengthens management with Lubor Gaal as Chief Financial Officer

Targovax ASA strengthens management with Lubor Gaal as Chief Financial Officer

Targovax ASA: Targovax awarded NOK 8.2m grant by Innovation Norway

Targovax ASA: Targovax awarded NOK 8.2m grant by Innovation Norway

Targovax ASA: ONCOS-102 achieves 25.0 months median overall survival in first line mesothelioma

Targovax ASA: ONCOS-102 achieves 25.0 months median overall survival in first line mesothelioma

Targovax ASA: Third quarter 2021 results

Targovax ASA: Third quarter 2021 results

Targovax: Presentation material for today's webcast

Targovax: Presentation material for today's webcast

Targovax ASA appoints Dr. Erik Digman Wiklund as new CEO

Targovax ASA appoints Dr. Erik Digman Wiklund as new CEO

Targovax to present at upcoming conferences

Targovax to present at upcoming conferences

Targovax ASA: Two abstracts accepted at the SITC Congress

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Circio Holding Asa (0RIS) Actualités

Circio Holding Asa (0RIS)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

0RIS Actualités

Targovax ASA strengthens management with Lubor Gaal as Chief Financial Officer

Targovax ASA strengthens management with Lubor Gaal as Chief Financial Officer

Targovax ASA: Targovax awarded NOK 8.2m grant by Innovation Norway

Targovax ASA: Targovax awarded NOK 8.2m grant by Innovation Norway

Targovax ASA: ONCOS-102 achieves 25.0 months median overall survival in first line mesothelioma

Targovax ASA: ONCOS-102 achieves 25.0 months median overall survival in first line mesothelioma

Targovax ASA: Third quarter 2021 results

Targovax ASA: Third quarter 2021 results

Targovax: Presentation material for today's webcast

Targovax: Presentation material for today's webcast

Targovax ASA appoints Dr. Erik Digman Wiklund as new CEO

Targovax ASA appoints Dr. Erik Digman Wiklund as new CEO

Targovax to present at upcoming conferences

Targovax to present at upcoming conferences

Targovax ASA: Two abstracts accepted at the SITC Congress

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités